1) marrow inhibitory period
骨髓抑制期
1.
Causes of hospital infection of patients with malignant hematologic diseases in marrow inhibitory period and the countermeasures
恶性血液病患者骨髓抑制期医院感染调查分析及对策
2) myelosuppression
骨髓抑制
1.
Abdominal pain,diarrhea and myelosuppression caused by oral methotrexate;
口服甲氨蝶呤引起腹痛、腹泻及骨髓抑制
2.
Pufferfish type Ⅰ collagen extract prevented and cured myelosuppression induced by cyclophosphamide or diamminedichloroplatinum or cytosine arabinoside in mice;
河鲀Ⅰ型胶原蛋白提取物防治环磷酰胺、顺铂或阿糖胞苷诱发小鼠骨髓抑制的研究
3.
35 Cases with AIDS Complicating Myelosuppression after HAART in the Jingyuankang Capsule;
精元康胶囊对艾滋病HAART疗法致骨髓抑制35例的临床观察
3) Bone marrow suppression
骨髓抑制
1.
Response of rhG-CSF (Rui Xuexin) in treating bone marrow suppression after concurrent chemotherapy puls radiotherapy;
瑞血新对同步放化疗后骨髓抑制的作用
2.
Treatment status of bone marrow suppression with cytokine;
生物因子治疗骨髓抑制的研究进展
3.
Severe bone marrow suppression after liver transplantation:a report of 6 cases;
肝移植术后并发严重骨髓抑制(附6例报告)
4) Bone marrow depression
骨髓抑制
1.
The effects of Thyrosin on prevention and treatment of bone marrow depression caused by chemotherapy in malignancies;
胸腺肽对肿瘤化疗病人骨髓抑制的防治作用
2.
Objective:To observe the effect of Tianjingchongsui Prescription (TP, 填 精 充 髓 方 ) on preventing bone marrow depression caused by chemotherapy.
目的观察自拟填精充髓方预防恶性肿瘤化疗患者骨髓抑制的疗效。
3.
The author here presented her theoretical and primary clinical studies on the chemotherapy- followed bone marrow depression.
本文综述了近十年来中医药治疗化疗后骨髓抑制的研究现状及进展,并系统的探讨了中西医对恶性肿瘤化疗后骨髓抑制的病因病机、治法方药。
5) Bone marrow inhibition
骨髓抑制
1.
Objective: To observe the curative effect of Guilu Erxian Dan (GED) for bone marrow inhibition (BMI) in mammary cancer after chemotherapy.
目的:观察龟鹿二仙丹加味对乳腺癌化疗后骨髓抑制的治疗作用。
6) Marrow Inhibition
骨髓抑制
1.
Effects of Smoke and Tea on Radiation-induced Bone Marrow Cell Mutation and Marrow Inhibition.;
烟、茶对放射线所致骨髓细胞突变和骨髓抑制的影响
2.
The efficacy of preventing and curing marrow inhibition induced by chemothorapy by using Hemarisin;
惠若舒防治恶性肿瘤化疗所致骨髓抑制的临床疗效研究
补充资料：骨髓
骨髓
bone marrow
充满骨内腔隙的柔软组织。约占体重的4.5%，是人体最大的造血器官。分为红骨髓和黄骨髓。胎儿及婴幼儿的骨髓都是红髓，约从5岁开始，长骨骨干骨髓腔内的红骨髓出现脂肪组织，红骨髓逐渐被黄骨髓所代替，黄骨髓随年龄增长而增多，成人的红骨髓和黄骨髓约各占一半。成人的红骨髓主要分布在扁骨、不规则骨及长骨骺端的松质骨中，具有活跃的造血功能。黄骨髓充满在长骨骨干的骨髓腔内，主要由脂肪组织构成，已停止造血，但黄骨髓仍保持着造血的潜能，当机体需要时还可转变为红骨髓进行造血。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条